1. Home
  2. CLF vs VKTX Comparison

CLF vs VKTX Comparison

Compare CLF & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cleveland-Cliffs Inc.

CLF

Cleveland-Cliffs Inc.

SELL

Current Price

$12.77

Market Cap

4.9B

ML Signal

SELL

VKTX

Viking Therapeutics Inc.

HOLD

Current Price

$28.39

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLF
VKTX
Founded
1847
2012
Country
United States
United States
Employees
25000
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.0B
IPO Year
2006
2014

Fundamental Metrics

Financial Performance
Metric
CLF
VKTX
Price
$12.77
$28.39
Analyst Decision
Hold
Strong Buy
Analyst Count
13
20
Target Price
$12.60
★ $94.71
AVG Volume (30 Days)
★ 15.0M
7.7M
Earning Date
10-19-2026
10-26-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $18,610,000,000.00
N/A
Revenue This Year
$15.97
N/A
Revenue Next Year
$4.15
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$7.73
$25.77
52 Week High
$16.70
$43.15

Technical Indicators

Market Signals
Indicator
CLF
VKTX
Relative Strength Index (RSI) 58.79 40.10
Support Level $11.78 N/A
Resistance Level $12.81 $34.98
Average True Range (ATR) 0.55 1.94
MACD 0.10 -0.50
Stochastic Oscillator 82.43 8.72

Price Performance

Historical Comparison
CLF
VKTX

About CLF Cleveland-Cliffs Inc.

Cleveland-Cliffs Inc is a flat-rolled steel producer and manufacturer of iron ore pellets in North America. It is organized into four operating segments based on differentiated products, Steelmaking, Tubular, Tooling and Stamping and European Operations, but operates through one reportable segment -Steelmaking. It is vertically integrated from mined raw materials, direct reduced iron, and ferrous scrap to primary steelmaking and downstream finishing, stamping, tooling and tubing. It serves a diverse range of other markets due to its comprehensive offering of flat-rolled steel products. Geographically, it operates in the United States, Canada and other countries. The majority of revenue is from the United States. It is a supplier of steel to the automotive industry in North America.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: